Logos Global Management LP
- SEC CIK
- 0001792126
- Latest filing
- Aug 14, 2026
DICE holding history
DICE Therapeutics, Inc. in every 13F filed by Logos Global Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DICE overviewAll 13F holders of DICEFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −410,000−100.0% | Sold out | Holders |
| Q1 2023 | 410,000 | $11.7M | 1.7% | −250,000−37.9% | Reduced | Holders |
| Q4 2022 | 660,000 | $20.6M | 2.4% | −425,251−39.2% | Reduced | Holders |
| Q3 2022 | 1,085,251 | $22.0M | 2.7% | +100,000+10.1% | Added | Holders |
| Q2 2022 | 985,251 | $15.3M | 2.8% | −400,000−28.9% | Reduced | Holders |
| Q1 2022 | 1,385,251 | $26.5M | 3.4% | −279,000−16.8% | Reduced | Holders |
| Q4 2021 | 1,664,251 | $42.1M | 4.3% | +504,000+43.4% | Added | Holders |
| Q3 2021 | 1,160,251 | $38.0M | 2.7% | +1,160,251 | New | Holders |